Status:

RECRUITING

Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients

Lead Sponsor:

Hôpital Européen Marseille

Conditions:

Systemic Sclerosis

Eligibility:

All Genders

18+ years

Brief Summary

Today, the study of gut microbiota has taken a prominent place in several fields of medical research. Numerous experimental data in humans and animals suggest that an imbalance in the composition of t...

Detailed Description

This is an explorative, prospective, monocentric open-label study qualified as interventional researches at minimal risks and constraints (called in French RIPH, category 2). This is a study of the g...

Eligibility Criteria

Inclusion

  • For ScS patients:
  • Patients with ScS according to ACR criteria.
  • Patients over 18 years old.
  • Patients who have signed the consent to participate in this study.
  • For control subjects:
  • Persons without diagnosis of ScS or any other chronic disease.
  • Persons over 18 years old.
  • Persons who have signed the consent to participate in this study

Exclusion

  • 1\. Persons with severe anemia (Hb \< 7 g/dL). 2. Persons who cannot read French. 3. For control subjects: Persons with a particular symptom (as an example of digestive disorders), or under long-term treatment related to another pathology.
  • 4\. Persons treated with antibiotics, probiotics, prebiotics or any other treatment that may disrupt the gut microbiota within two months before stool sampling.
  • 5\. Persons referred to the article L1121-5 to 1121-8 of the Public health code, namely :
  • Pregnant, women in labour and breastfeeding mothers.
  • Persons deprived of their liberty by a judicial or administrative decision.
  • Persons undergoing psychiatric follow-up.
  • Minors
  • Persons of full-age who are subject to a legal protection measure or who are unable to express their consent.

Key Trial Info

Start Date :

October 8 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 3 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04132206

Start Date

October 8 2019

End Date

June 3 2026

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Européen Marseille

Marseille, France, 13003